Journal of Medicinal Chemistry
Basic Information
Journal of Medicinal Chemistry publishes studies that contribute to an understanding of the relationship between molecular structure and biological activity or mode of action. Some specific areas that are appropriate include the following: Design, synthesis, and biological evaluation of novel biologically active compounds, diagnostic agents, or labeled ligands employed as pharmacological tools. Molecular modifications of reported series that lead to a significantly improved understanding of their structure-activity relationships (SAR). Routine extensions of existing series that do not utilize novel chemical or biological approaches or do not add significantly to a basic understanding of the SAR of the series will normally not be accepted for publication. Structural biological studies (X-ray, NMR, etc.) of relevant ligands and targets with the aim of investigating molecular recognition processes in the action of biologically active compounds. Molecular biological studies (e.g., site-directed mutagenesis) of macromolecular targets that lead to an improved understanding of molecular recognition. Computational studies that provide fresh insight into the SAR of compound series that are of current general interest or analysis of other available data that subsequently advance medicinal chemistry knowledge. Substantially novel computational chemistry methods with demonstrated value for the identification, optimization, or target interaction analysis of bioactive molecules. Effect of molecular structure on the distribution, pharmacokinetics, and metabolic transformation of biologically active compounds. This may include design, synthesis, and evaluation of novel types of prodrugs. Novel methodology with broad application to medicinal chemistry, but only if the methods have been tested on relevant molecules.
CiteScore
| Subject | Rank | Percentile |
|---|---|---|
Pharmacology, Toxicology and PharmaceuticsDrug Discovery |
5 / 146 | 96% |
Journal Statistics
Submission Information
Submission Website:
https://acs.manuscriptcentral.com/acsAccepted Types:
Brief Articles
Perspectives
Drug Annotations
Viewpoint
Featured Articles
Recommended Journals
Related Articles
Dynamic structural conversion in a spin-crossover cobalt(ii) compound with long alkyl chains
Shinya Hayami, Kazuhisa Murata, Daisuke Urakami, Yoshihiro Kojima, Motoko Akita
DOI: 10.1039/B814415J
Polyfunctional benzylic zinc chlorides by the direct insertion of magnesium into benzylic chlorides in the presence of LiCl and ZnCl2
Albrecht Metzger, Fabian M. Piller, Paul Knochel
DOI: 10.1039/B812396A
Preparation of active and robust palladium nanoparticlecatalysts stabilized by diamine-functionalized mesoporous polymers
Rong Xing, Yueming Liu, Haihong Wu, Xiaohong Li, Mingyuan He, Peng Wu
DOI: 10.1039/B815186E
Efficient mono- and bis-functionalization of 3,6-dichloropyridazine using (tmp)2Zn·2MgCl2·2LiCl
Stefan Wunderlich, Paul Knochel
DOI: 10.1039/B815903C
Chemiluminescence thrombin aptasensor using high-activity DNAzyme as catalytic label
DOI: 10.1039/B809296F
Amplified fluorescence determination of microRNAs in homogeneous solution with cationic conjugated polymers
Zhengping Li, Yongqiang Cheng
DOI: 10.1039/B816614E
One-phase synthesis of small gold nanoparticles coated by a horizontal porphyrin monolayer
Junya Ohyama, Yasuhiro Higuchi, Masashi Shinagawa, Hidefumi Mukai, Masahito Kodera, Kentaro Teramura, Tetsuya Shishido, Tsunehiro Tanaka
DOI: 10.1039/B815100H
A diastereoselective route to 2,6-syn-disubstituted tetrahydropyrans: synthesis of the civet compound (+)-2-((2S,6S)-6-methyltetrahydro-2H-pyran-2-yl) acetic acid
Matthew O’Brien, Shane Cahill, Lyndsay A. Evans
DOI: 10.1039/B810231G
Wet-chemical approach for the halogenation of hydrogenated boron-doped diamond electrodes
Manash R. Das, Vera G. Praig, Francois LeNormand, Musen Li, Rabah Boukherroub
DOI: 10.1039/B810975C
The crystal structure of β-RDX—an elusive form of an explosive revealed
David I. A. Millar, Iain D. H. Oswald, Duncan J. Francis, William G. Marshall, Colin R. Pulham, Adam S. Cumming
DOI: 10.1039/B817966B
You might also like
What is Ethyl 3-cyclohexylpropanoate (CAS: 10094-36-7)?
Ethyl 3-cyclohexylpropanoate is a clear, colorless to light yellow liquid with a...
How should waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)nicotinic acid (CAS: 34783-31-8) be handled?
Waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl...
How should waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) be handled?
Waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) sho...
What precautions should be taken when handling Chloroac-nle-oh (CAS: 56787-36-1)?
When handling Chloroac-nle-oh (CAS: 56787-36-1), it is essential to wear appropr...
What industries use Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate (CAS: 752244-05-6)?
Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate is primarily used in the...
Are there alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis?
Alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis ...
How should waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) be handled?
Waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) should be managed...
What industries use 1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9)?
1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9) is used in various ...
Are there alternatives to 3-Bromo-5-(N-Boc)aminomethylisoxazole (CAS: 903131-45-3) in synthesis?
There are alternative reagents and compounds that can be used in the synthesis o...
What is Tungsten(IV) oxide (CAS: 12036-22-5)?
Tungsten(IV) oxide, also known as tungsten dioxide, is a chemical compound with ...















![[2',6'-bis(propan-2-yloxy)-[1,1'-biphenyl]-3-yl]dicyclohexylphosphane structure [2',6'-bis(propan-2-yloxy)-[1,1'-biphenyl]-3-yl]dicyclohexylphosphane structure](https://static.chemtradehub.com/structs/787/787618-22-8-dda2.webp)


